Utility of a new notation to visualize flow cytometry analysis results: first preliminary comparison with immunohistochemistry to detect CD30 expression on T-cell lymphoma cells

被引:0
作者
Fumiyoshi Fujishima
Noriko Fukuhara
Hiroki Katsushima
Yasuhiro Nakamura
Hideo Harigae
Hironobu Sasano
Ryo Ichinohasama
机构
[1] Tohoku University Hospital,Department of Pathology
[2] Tohoku University Graduate School of Medicine,Department of Hematology and Rheumatology
[3] Osaka Red Cross Hospital,Department of Diagnostic Pathology
[4] Tohoku Medical and Pharmaceutical University,Division of Pathology
[5] Tohoku University Graduate School of Medicine,Department of Pathology
[6] Tohoku University Hospital,Division of Hematopathology
来源
BMC Cancer | / 21卷
关键词
Flow cytometry; CD30; Immunohistochemistry; Malignant lymphoma; Notation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 94 条
[1]  
Nomura E(2004)Multiparameter analysis for discreet differential diagnosis of mucosa-associated lymphoid tissue lymphoma in the intestine In Vivo 18 437-441
[2]  
Takagi S(2015)First case of primary intraocular natural killer t-cell lymphoma BMC Ophthalmol 15 169-1903
[3]  
Ichinohasama R(1997)Three-color flow cytometry in the diagnosis of malignant lymphoma based on the comparative cell morphology of lymphoma cells and reactive lymphocytes Leukemia. 11 1891-e82
[4]  
Kikuchi T(2013)CD30 expression in peripheral T-cell lymphomas Haematologica. 98 e81-1402
[5]  
Shiraki M(2015)Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression Blood. 125 1394-787
[6]  
Oomori S(2021)The expression of CD30 and its clinico-pathologic significance in peripheral T-cell lymphomas Expert Rev Hematol 14 777-118
[7]  
Maruyama K(2019)Immunohistochemical pattern of c-MYC protein judged as “+/(weak)+/− ” by a new notation correlates with MYC gene nontranslocation in large B-cell lymphoma Hum Pathol 85 112-500
[8]  
Kunikata H(2017)BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation Blood. 130 489-1786
[9]  
Sugita S(1995)Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL) Leukemia. 9 1783-1909
[10]  
Mochizuki M(1998)Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89 Blood. 92 1898-161